Proposed Data Collections Submitted for Public Comment and Recommendations, 28478-28479 [E8-10935]
Download as PDF
<![CDATA[
28478
Federal Register / Vol. 73, No. 96 / Friday, May 16, 2008 / Notices
sroberts on PROD1PC70 with NOTICES
the review and monitoring of awardee
progress.
2. Provide a timely documentation
package to the GMO regarding a
decision to repay unobligated HPP
funds that exceed the maximum
carryover percentage.
B. GMO shall:
1. Rescind initial failure notification
or issue a final failure notification and
provide the awarding agency’s process
for appeal to include applicable
timelines, in writing, to the awardee and
provide a copy to ARC.
2. Brief ARC on issues pertaining to
disputes.
3. Prepare and submit a complete
documentation package to the ARC
regarding a decision to repay.
C. ARC shall:
1. Establish regular committee
members and consult with subject
matter experts in the Department, as
necessary.
2. Receive initial Notice of Appeals.
3. Send acknowledgements to the
awardee and GMO.
4. Review disputes by documentation
or conference.
5. Provide recommendations and
facilitate disputes to preclude further
action.
6. Provide the ARC decisions on
appeals.
D. Awardee or Complainant shall:
1. Remedy non-compliance issues
during the corrective action phase. If the
GMO determines that corrective actions
have not been adequate, the awardee
may submit a written request for review.
2. If awardee disputes the GMO’s final
decisions, submit dispute to ARC after
Failure Notification is received from the
agency awarding office as described in
the NoA. The dispute must contain the
following:
A. A detailed description of the
reason for dispute including supporting
documentation;
B. A description of how the
enforcement action impacts the affected
organization; and
C. Request for a waiver of repayment
that includes an explanation why such
requirement (for maximum percentage
of carryover amount) should not apply
to the awardee and the steps taken by
the awardee to ensure that all HPP
funds will be expended appropriately.
C. Repayment or Future Withholding or
Offset as a Result of a Disallowance
Decision if an Audit Shows That Funds
Have Not Been Spent in Accordance
With Section 319C–2 of the PHS Act
1. Awardees shall, not less often than
once every 2 years, audit their
expenditures from HPP funds received.
Such audits shall be conducted by an
VerDate Aug<31>2005
16:18 May 15, 2008
Jkt 214001
entity independent of the agency
administering the HPP program in
accordance with the Comptroller
General’s standards for auditing
governmental organizations, programs,
activities, and functions and generally
accepted auditing standards. Within 30
days following completion of each audit
report, awardees should submit a copy
of that audit report to ASPR.
Awardees shall repay to the United
States amounts found not to have been
expended in accordance with section
319C–2 of the PHS Act. If such
repayment is not made, ASPR may
offset such amounts against the amount
of any allotment to which the awardee
is or may become entitled under section
319C–2 or may otherwise recover such
amount. ASPR may withhold payment
of funds to any awardee which is not
using its allotment under section 319C–
2 in accordance with such section.
ASPR may withhold such funds until it
finds that the reason for the withholding
has been removed and there is
reasonable assurance that it will not
recur.
• 45 CFR Part 74 and Appendix E,
Uniform Administrative Requirements
for Awards and Sub-awards to
Institutions of Higher Education,
Hospitals, Other Nonprofit
organizations, and commercial
organizations.
• 45 CFR Part 92, Uniform
Administrative Requirements for Grants
and Cooperative Agreements to State,
Local, and Tribal Governments.
B. OMB Circulars
• A–87, Cost Principles for State,
Local and Indian Tribal Governments.
• A–102, Grants and Cooperative
Agreements with State and Local
Governments.
• A–110, Uniform Administrative
Requirements for Grants and Other
Agreements with Institutions of Higher
Education, Hospitals, and Other NonProfit Organizations.
• A–133, Audits of States, Local
Governments, and Non-Profit
Organizations Requirements.
C. HHS Grants Policy Statement,
January 1, 2007
2. Disallowance notification
[FR Doc. E8–11015 Filed 5–15–08; 8:45 am]
Upon determination as a result of
audit findings that the awardee has not
expended funds in accordance with
section 319C–2, the GMO shall issue a
disallowance notification to the awardee
for the portion of funds not expended in
accordance with section 319C–2 and
require repayment of those funds to the
United States.
BILLING CODE 4150–37–P
3. Dispute process
Proposed Data Collections Submitted
for Public Comment and
Recommendations
HHS has established a DAB for the
purpose of providing awardees a fair
and flexible process to appeal certain
written final decisions involving grant
and cooperative agreement programs
administered by agencies of HHS. This
document notifies HPP awardees that an
opportunity exists to appeal a
disallowance enforcement action to the
DAB. If the awardee chooses to appeal
a final disallowance decision by the
GMO, the awardee must do so directly
to the DAB within thirty days of receipt
of the GMO’s final disallowance
notification. The Notice of Appeal shall
include: (1) A copy of the final decision,
(2) a statement of the amount in dispute
in the appeal, and (3) a brief statement
of why the decision is wrong. More
details about the DAB’s procedures may
be found at 45 CFR part 16.
V. References
A. Code of Federal Regulations (CFR)
• 45 CFR Part 16 and Appendix A,
Procedures of the Departmental Grants
Appeal Board.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–08–08BD]
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
E:\FR\FM\16MYN1.SGM
16MYN1
28479
Federal Register / Vol. 73, No. 96 / Friday, May 16, 2008 / Notices
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Survey of HIV Testing in
Hospitals—New—National Center for
HIV, Viral Hepatitis, STD and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Early identification of HIV infection
has significant benefits to the infected
individual and society. In light of recent
advancements in HIV testing and
treatment, the Centers for Disease
Control and Prevention (CDC) released
its prevention initiative, Advancing HIV
Prevention: New Strategies for a
Changing Epidemic. A key component
of this strategy focuses upon increased
HIV testing in healthcare settings to
increase the number of persons with
HIV who are aware of their infection
and are successfully referred to
treatment and prevention services. In
September 2006, CDC released revised
recommendations for routine HIV
CDC is requesting approval for a 2year clearance for data collection. This
project will collect data from hospitals
on a one-time voluntary basis using a
brief survey. Surveys will be completed
by the hospital administrators at each
site who are most knowledgeable on
HIV testing practices, infection control,
and laboratory procedures for their site,
in consultation with other hospital staff,
as necessary. Collection of data will
provide information on current HIV
testing practices and policies for the
hospital; use of point-of-care and
conventional HIV tests; and barriers and
facilitators of hospital-based HIV
testing.
Data will be requested from a
representative sample of 4,927 U.S.
community hospitals. Surveys will be
sent to approximately 1,000 hospital
sites with an estimated 70% response
rate, based upon estimates from
response rates from prior similar
surveys among U.S. hospitals. This will
result in approximately 700
participating hospital sites, representing
approximately 15% of U.S. community
hospitals. The average duration of the
survey, including time required to
collect the requested data, is estimated
to be 4 hours per hospital site. There is
no cost to the participating hospitals
other than their time.
testing of adults, adolescents, and
pregnant women in healthcare settings
as a measure to address the high number
of individuals who are unaware of their
HIV infection.
Routine HIV testing programs in
hospital settings, including emergency
departments (EDs) and urgent care
centers (UCCs), have great potential to
identify a large number of previously
undiagnosed individuals. Prior to the
release of the revised recommendations,
few such hospital-based testing
programs had existed in the United
States. CDC is committed to increasing
the number of such programs in the
U.S., and is currently working with
partners to achieve these goals. This
project proposes a survey to assess HIV
testing policies and practices in
hospitals nationwide and to describe the
up-take of the revised HIV testing
recommendations for hospital settings.
The objectives of this project are: (1)
To determine the extent to which HIV
testing is being conducted in U.S.
hospitals; (2) to describe the
characteristics of hospitals with and
without HIV testing programs; and (3) to
identify barriers to and facilitators of
implementing HIV testing programs in
these settings. This data will assist CDC
in monitoring the uptake of
recommendations for HIV testing in
healthcare settings.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of form
Average
burden
per response
in hours
Number of
responses per
respondent
Total burden
in hours
Hospital Survey ................................................................................................
700
1
4
2,800
Total ..........................................................................................................
........................
........................
........................
2,800
Dated: May 8, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–10935 Filed 5–15–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sroberts on PROD1PC70 with NOTICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
VerDate Aug<31>2005
16:18 May 15, 2008
Jkt 214001
announces the following council
meeting.
Name: Advisory Council for the
Elimination of Tuberculosis
Times and Dates:
8:30 a.m.–5 p.m., June 17, 2008.
8:30 a.m.–2 p.m., June 18, 2008.
Place: Corporate Square, Building 8, 1st
Floor Conference Room, Atlanta, Georgia
30333, telephone (404) 639–8317.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This council advises and makes
recommendations to the Secretary of Health
and Human Services, the Assistant Secretary
for Health, and the Director, CDC, regarding
the elimination of tuberculosis. Specifically,
the Council makes recommendations
regarding policies, strategies, objectives, and
priorities; addresses the development and
application of new technologies; and reviews
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
the extent to which progress has been made
toward eliminating tuberculosis.
Matters to be Discussed: Agenda items
include issues pertaining to the Findings
from the Philippine Technical Instruction
Program Review; Division of Tuberculosis
Training, Informatics, Surveillance and
Research Issues; and Discussion on the Office
of Management and Budget (OMB) and
Genomics, and other related Tuberculosis
Issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, Coordinating Center for
Infectious Diseases, Strategic Business Unit,
1600 Clifton Road, NE., M/S E–07, Atlanta,
Georgia 30333, telephone (404) 639–8317.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
E:\FR\FM\16MYN1.SGM
16MYN1
]]>Agencies
[Federal Register Volume 73, Number 96 (Friday, May 16, 2008)]
[Notices]
[Pages 28478-28479]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-10935]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-08-08BD]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c)
[[Page 28479]]
ways to enhance the quality, utility, and clarity of the information to
be collected; and (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology. Written
comments should be received within 60 days of this notice.
Proposed Project
National Survey of HIV Testing in Hospitals--New--National Center
for HIV, Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Early identification of HIV infection has significant benefits to
the infected individual and society. In light of recent advancements in
HIV testing and treatment, the Centers for Disease Control and
Prevention (CDC) released its prevention initiative, Advancing HIV
Prevention: New Strategies for a Changing Epidemic. A key component of
this strategy focuses upon increased HIV testing in healthcare settings
to increase the number of persons with HIV who are aware of their
infection and are successfully referred to treatment and prevention
services. In September 2006, CDC released revised recommendations for
routine HIV testing of adults, adolescents, and pregnant women in
healthcare settings as a measure to address the high number of
individuals who are unaware of their HIV infection.
Routine HIV testing programs in hospital settings, including
emergency departments (EDs) and urgent care centers (UCCs), have great
potential to identify a large number of previously undiagnosed
individuals. Prior to the release of the revised recommendations, few
such hospital-based testing programs had existed in the United States.
CDC is committed to increasing the number of such programs in the U.S.,
and is currently working with partners to achieve these goals. This
project proposes a survey to assess HIV testing policies and practices
in hospitals nationwide and to describe the up-take of the revised HIV
testing recommendations for hospital settings.
The objectives of this project are: (1) To determine the extent to
which HIV testing is being conducted in U.S. hospitals; (2) to describe
the characteristics of hospitals with and without HIV testing programs;
and (3) to identify barriers to and facilitators of implementing HIV
testing programs in these settings. This data will assist CDC in
monitoring the uptake of recommendations for HIV testing in healthcare
settings.
CDC is requesting approval for a 2-year clearance for data
collection. This project will collect data from hospitals on a one-time
voluntary basis using a brief survey. Surveys will be completed by the
hospital administrators at each site who are most knowledgeable on HIV
testing practices, infection control, and laboratory procedures for
their site, in consultation with other hospital staff, as necessary.
Collection of data will provide information on current HIV testing
practices and policies for the hospital; use of point-of-care and
conventional HIV tests; and barriers and facilitators of hospital-based
HIV testing.
Data will be requested from a representative sample of 4,927 U.S.
community hospitals. Surveys will be sent to approximately 1,000
hospital sites with an estimated 70% response rate, based upon
estimates from response rates from prior similar surveys among U.S.
hospitals. This will result in approximately 700 participating hospital
sites, representing approximately 15% of U.S. community hospitals. The
average duration of the survey, including time required to collect the
requested data, is estimated to be 4 hours per hospital site. There is
no cost to the participating hospitals other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of form respondents responses per response in in hours
respondent hours
----------------------------------------------------------------------------------------------------------------
Hospital Survey................................. 700 1 4 2,800
---------------------------------------------------------------
Total....................................... .............. .............. .............. 2,800
----------------------------------------------------------------------------------------------------------------
Dated: May 8, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E8-10935 Filed 5-15-08; 8:45 am]
BILLING CODE 4163-18-P
